These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 17010756

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Once-daily fexofenadine treatment for chronic idiopathic urticaria: a multicenter, randomized, double-blind, placebo-controlled study.
    Kaplan AP, Spector SL, Meeves S, Liao Y, Varghese ST, Georges G.
    Ann Allergy Asthma Immunol; 2005 Jun; 94(6):662-9. PubMed ID: 15984599
    [Abstract] [Full Text] [Related]

  • 4. Levocetirizine in the treatment of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study.
    Nettis E, Colanardi MC, Barra L, Ferrannini A, Vacca A, Tursi A.
    Br J Dermatol; 2006 Mar; 154(3):533-8. PubMed ID: 16445787
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Rupatadine in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled multicentre study.
    Gimenez-Arnau A, Pujol RM, Ianosi S, Kaszuba A, Malbran A, Poop G, Donado E, Perez I, Izquierdo I, Arnaiz E, Rupatadine Urticaria Study Group.
    Allergy; 2007 May; 62(5):539-46. PubMed ID: 17441794
    [Abstract] [Full Text] [Related]

  • 7. Cyclosporine A in rheumatoid arthritis: randomized, placebo controlled dose finding study.
    Altman RD, Schiff M, Kopp EJ.
    J Rheumatol; 1999 Oct; 26(10):2102-9. PubMed ID: 10529124
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A randomized, double-blind, multicenter, controlled clinical trial of cyclosporine plus chloroquine vs. cyclosporine plus placebo in early-onset rheumatoid arthritis.
    Miranda JM, Alvarez-Nemegyei J, Saavedra MA, Terán L, Galván-Villegas F, García-Figueroa J, Jara LJ, Barile L, GRECIA Group.
    Arch Med Res; 2004 Oct; 35(1):36-42. PubMed ID: 15036798
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Extended cyclosporine-A--treatment for severe chronic urticaria].
    Kessel A, Toubi E.
    Harefuah; 2006 Jun; 145(6):411-4, 471. PubMed ID: 16838894
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of short- and long-term cyclosporine A therapy in chronic idiopathic urticaria.
    Baskan EB, Tunali S, Turker T, Saricaoglu H.
    J Dermatolog Treat; 2004 Jun; 15(3):164-8. PubMed ID: 15204149
    [Abstract] [Full Text] [Related]

  • 17. Once-daily rupatadine improves the symptoms of chronic idiopathic urticaria: a randomised, double-blind, placebo-controlled study.
    Dubertret L, Zalupca L, Cristodoulo T, Benea V, Medina I, Fantin S, Lahfa M, Pérez I, Izquierdo I, Arnaiz E.
    Eur J Dermatol; 2007 Jun; 17(3):223-8. PubMed ID: 17478385
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
    Chihara K, Kato Y, Kohno H, Takano K, Tanaka T, Teramoto A, Shimatsu A.
    Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
    [Abstract] [Full Text] [Related]

  • 20. [Double-blind comparative study of terfenadine and cetirizine in chronic idiopathic urticaria].
    Lambert D, Hantzperg M, Danglas P, Bloom M.
    Allerg Immunol (Paris); 1993 Jun; 25(6):235-40. PubMed ID: 8357472
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.